John R Fischer

PE targets growing telehealth demand: 6 deals

Clearview Capital, Berkshire Partners, Grovecourt Capital Partners and The Vistria Group are among the PE firms investing in telehealth.

Tech deal processes will kick off after Labor Day, predicts Clearlake’s Prashant Mehrotra; Disruption Matters podcast features AI tools

A Q&A with Prashant Mehrotra, partner and managing director at Clearlake Capital Group, who discussed his outlook for tech sector M&A in the second half of 2025 and how AI is expected to drive deals within the sector; the latest episode of the fourth season of the Disruption Matters podcast miniseries has dropped and features leaders at Goldman Sachs, Partners Group, AlixPartners, BayPine and Prysm Capital discussing best practices for leveraging AI to help companies grow.

Animal health industry is a sweet spot for PE investors

Polaris, RF Investment Partners and Partners Group are investing in animal pharma in several areas.

KKR, CVC, MidEuropa target hospitals; Waud launches medical supply chain platform

Continuous M&A opportunities and increasing care demands are among the reasons why firms like KKR, CVC Capital and MidEuropa are still betting on the hospital sector; spotlighting a recently announced partnership between Waud Capital Partners and healthcare executive Bill Mixon to build a new platform focused on the medical device and supply chain services market.

PE targets stakes in hospital sector: 5 deals

KKR, CVC Capital, MidEuropa and Ontario Teachers are among those pursuing investments in hospitals.

Permira's Jon Maschmeyer: 'The future of patient services in biopharma is really being driven by innovation'

'Integrated, tech-forward platforms are going to define the next chapter of healthcare commercialization, and this merger puts Valeris right at the forefront of that shift.'

BC Partners, Brookfield and CDPQ bet on medical consumables; Vitamin and supplement M&A thriving amid headwinds

A 6-deal listicle from the consistent need to replenish gloves, syringes and other medical consumables; Linden Capital Partners and GIC are among the latest firms to make a move in the pharma commercialization segment; deal volume in the vitamins and supplements sector has increased by quite a margin from last year’s figures, according to Capstone Partners’ latest M&A report.

PE stocks up on medical consumables: 6 deals

BC Partners, GTCR, JLL Partners and Waud Capital Partners are among the PE firms investing in the medical consumables sector.

Exclusive: DuneGlass platform Allied OMS acquires four oral care practices

DuneGlass launched Allied OMS, a doctor-led and -owned MSO for oral and maxillofacial surgical care providers, in 2020.

Behavioral health, pediatrics still viable for private equity, but Medicaid-dependent hospitals, nursing homes less attractive

As the budget bill heads back to the House, PE Hub turns to Reed Smith's Nicole Aiken-Shaban to gauge the potential impact on PE healthcare deals.